HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL SUPPORT IN FIRST LINE TREATMENT OF AGGRESSIVE NON HODGKIN LYMPHOMA: RESULTS OF AN INDIVIDUAL PATIENT DATA META-ANALYSIS

被引:0
|
作者
Brillant, C. [1 ]
Schwarzer, G. [2 ]
Bohlius, J. [3 ]
Greb, A. [1 ]
Trelle, S. [3 ]
Haioun, C. [4 ]
De Souza, A. [5 ]
Gisselbrecht, C. [6 ]
Intragumtornchai, T. [7 ]
Kaiser, U. [8 ]
Kluin-Nelemans, C. [9 ]
Martelli, M. [10 ]
Milpied, N. [11 ]
Verdonck, F. [12 ]
Vitolo, U. [13 ]
Engert, A. [14 ]
Schulz, H. [14 ]
机构
[1] Cochrane Hematol Malignancies Grp, Cologne, Germany
[2] German Cochrane Ctr, Dept Med Biometry & Stat, Freiburg, Germany
[3] Inst Social & Prevent Med, Bern, Switzerland
[4] Hop Henri Mondor, Lymphoid Malignancies Unit, F-94010 Creteil, France
[5] Univ Estadual Campinas, Campinas, SP, Brazil
[6] Hosp St Louis, INSERM, U728, Dept Hematol Oncol, Paris, France
[7] Chulalongkorn Univ, Div Hematol, Dept Med, Bangkok, Thailand
[8] St Bernward Hosp, Dept Hematol, Hildesheim, Germany
[9] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9713 AV Groningen, Netherlands
[10] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[11] Hop Haut Eveque, Serv Malad Sang, Bordeaux, France
[12] Isala Clin, Zwolle, Netherlands
[13] Univ San Giovanni Battista, Sect Hematol, Dept Oncol, Turin, Italy
[14] Univ Hosp Cologne, Cochrane Hematol Malignancies Grp, Cologne, Germany
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0974
引用
收藏
页码:392 / 392
页数:1
相关论文
共 50 条
  • [1] High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis
    Greb, Alexander
    Bohlius, Julia
    Trelle, Sven
    Schiefer, Daniel
    De Souza, Carmino A.
    Gisselbrecht, Christian
    Lntragumtornchai, Tanin
    Kaiser, Ulrich
    Kluin-Nelemans, Hanneke C.
    Martelli, Maurizio
    Milpied, Noel Jean
    Santini, Gino
    Verdonck, Leo F.
    Vitolo, Umberto
    Schwarzer, Guido
    Engert, Andreas
    CANCER TREATMENT REVIEWS, 2007, 33 (04) : 338 - 346
  • [2] High-dose chemotherapy with autologous stem cell support does not improve outcome in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis
    Greb, A
    Bohlius, J
    Schwarzer, G
    Schiefer, D
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 : 55 - 55
  • [3] High-dose chemotherapy with autologous stem cell support is not superior to conventional-dose chemotherapy in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis.
    Greb, A
    Schiefer, DH
    Bohlius, J
    Schwarzer, G
    Engert, A
    BLOOD, 2004, 104 (11) : 263A - 263A
  • [4] THE ROLE OF HIGH DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST LINE TREATMENT IN PATIENTS WITH AGGRESSIVE NON-HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Dahan-Shriki, D.
    Gafter-Gvili, A.
    Vidal, L.
    Raanani, P.
    Shpilberg, O.
    Gurion, R.
    HAEMATOLOGICA, 2014, 99 : 696 - 696
  • [5] Meta-analysis of randomised trials comparing high-dose chemotherapy with autologous stem cell support as part of first-line therapy with conventional chemotherapy in aggressive non-Hodgkin lymphoma - First results.
    Greb, A
    Bohlius, J
    Schiefer, D
    Schwarzer, G
    Engert, A
    BLOOD, 2003, 102 (11) : 734A - 734A
  • [6] High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma:: a meta-analysis
    Strehl, J
    Mey, U
    Glasmacher, A
    Djulbegovic, B
    Mayr, C
    Gorschlüter, M
    Ziske, C
    Schmidt-Wolf, IGH
    HAEMATOLOGICA, 2003, 88 (11) : 1304 - 1315
  • [7] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
    Greb, A.
    Bohlius, J.
    Schiefer, D.
    Schwarzer, G.
    Schulz, H.
    Engert, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [8] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Wang, Jing
    Zhan, Ping
    Ouyang, Jian
    Chen, Bing
    Zhou, Rongfu
    Yang, Yonggong
    MEDICAL ONCOLOGY, 2011, 28 (03) : 822 - 828
  • [9] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Jing Wang
    Ping Zhan
    Jian Ouyang
    Bing Chen
    Rongfu Zhou
    Yonggong Yang
    Medical Oncology, 2011, 28 : 822 - 828
  • [10] Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma
    Fagnoni, Philippe
    Milpied, Noel
    Limat, Samuel
    Deconinck, Eric
    Nerich, Virginie
    Foussard, Charles
    Colombat, Philippe
    Harousseau, Jean-Luc
    Woronoff-Lemsi, Marie-Christine
    PHARMACOECONOMICS, 2009, 27 (01) : 55 - 68